GLP‐1 s are insulinotropic agents in patients with type 2 diabetes mellitus (T2DM) that reduce plasma glucose, as well as glucagon secretion, slow gastric emptying, while also reducing caloric intake [18]. Here, GLP1R is linked to type 2 diabetes mellitus.